Phase II study of metronomic treatment with daily oral vinorelbine as first-line chemotherapy in patients with advanced/metastatic HR+/HER2− breast cancer resistant to endocrine therapy : VinoMetro—AGO-B-046 - Krajnak, Slavomir; Decker, Thomas; Schollenberger, Lukas; Rosé, Christian; Ruckes, Christian; Fehm, Tanja; Thomssen, Cristoph; Harbeck, Nadia; Schmidt, Marcus (Springer, 2021)
Keywords: 610 Medizin; 610 Medical sciences